SAN DIEGO, March 14, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the chief in spine know-how innovation, centered on reworking spine surgical procedure with minimally disruptive, procedurally built-in options, at this time introduced its continued participation on the 2023 Backbone Summit held March 16-19 in Miami and the Worldwide Assembly on Superior Backbone Methods (IMAST) held March 22-25 in Dublin.
“The Scoliosis Analysis Society (SRS), American Affiliation of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) are main societies that assist collect our business via a shared imaginative and prescient of ongoing analysis, scientific and academic efforts for higher affected person care,” mentioned Chris Barry, chief government officer at NuVasive. “As we have a good time 20 years of our flagship XLIF process, we proceed to be steadfast within the significance of clinically validated options, and our help of main societies underscores the need of data-backed spine and orthopedic innovation.”
At Backbone Summit (sales space #228) and IMAST (stand 6), study NuVasive’s complete, procedurally built-in portfolios—X360, C360, P360 and Complicated—enabled by the Pulse platform. Extra actions at every convention embody:
- Backbone Summit: Particular course, Improvements in Backbone, will function product demos of the Pulse platform on March 16 from 1:30 to 4:30 p.m. ET.
- IMAST: NuVasive-hosted workshop, Clever Surgical procedure for Complicated Backbone, will function Drs. David Okonkwo and Justin Smith as they evaluation technology-driven methods and instruments to maximise outcomes for difficult spine circumstances on March 23 from 12:15 to 1:15 p.m. GMT.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the chief in spine know-how innovation, with a mission to rework surgical procedure, advance care, and alter lives. The Firm’s less-invasive, procedurally built-in surgical options are designed to ship reproducible and clinically confirmed outcomes. The Firm’s complete procedural portfolio contains surgical entry devices, spinal implants, fixation techniques, biologics, software program for surgical planning, navigation and imaging options, magnetically adjustable implant techniques for spine and orthopedics, and intraoperative neuromonitoring know-how and repair choices. With greater than $1 billion in internet gross sales, NuVasive operates in additional than 50 nations serving surgeons, hospitals, and sufferers. For extra data, please go to www.nuvasive.com.
Ahead-Wanting Statements
NuVasive cautions you that statements included on this information launch that aren’t an outline of historic info are forward-looking statements that contain dangers, uncertainties, assumptions and different components which, if they don’t materialize or show right, may trigger NuVasive’s outcomes to vary materially from historic outcomes or these expressed or implied by such forward-looking statements. The potential dangers and uncertainties which contribute to the unsure nature of those statements embody, amongst others, dangers related to acceptance of the Firm’s surgical merchandise and procedures by spine surgeons and hospitals, growth and acceptance of latest merchandise or product enhancements, scientific and statistical verification of the advantages achieved through the usage of NuVasive’s merchandise, the Firm’s means to adequately handle stock because it continues to launch new merchandise, its means to recruit and retain administration and key personnel, and the opposite dangers and uncertainties described in NuVasive’s information releases and periodic filings with the Securities and Trade Fee. NuVasive’s public filings with the Securities and Trade Fee can be found at www.sec.gov. NuVasive assumes no obligation to replace any forward-looking assertion to replicate occasions or circumstances arising after the date on which it was made.
SOURCE NuVasive, Inc.
Discussion about this post